These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23963720)

  • 1. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity.
    Cellai AP; Lami D; Antonucci E; Liotta AA; Rogolino A; Fedi S; Fiorillo C; Becatti M; Cenci C; Marcucci R; Abbate R; Prisco D
    J Thromb Thrombolysis; 2014 Jul; 38(1):45-9. PubMed ID: 23963720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential.
    Colucci M; Cattaneo M; Martinelli I; Semeraro F; Binetti BM; Semeraro N
    J Thromb Haemost; 2008 Sep; 6(9):1571-7. PubMed ID: 18624976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
    Sauls DL; Wolberg AS; Hoffman M
    J Thromb Haemost; 2003 Feb; 1(2):300-6. PubMed ID: 12871504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
    Carr ME; Alving BM
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of homocysteine on fibrin network lysis.
    Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
    Thromb Haemost; 2021 Apr; 121(4):529-537. PubMed ID: 33186996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolism.
    Ząbczyk M; Natorska J; Malinowski KP; Undas A
    Vascul Pharmacol; 2020; 133-134():106783. PubMed ID: 32835836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity.
    Lami D; Cellai AP; Antonucci E; Fiorillo C; Becatti M; Grifoni E; Cenci C; Marcucci R; Mannini L; Miniati M; Abbate R; Prisco D
    Thromb Res; 2014 Sep; 134(3):737-41. PubMed ID: 25074740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
    Sakharov DV; Lijnen HR; Rijken DC
    J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis.
    Morris TA; Marsh JJ; Chiles PG; Auger WR; Fedullo PF; Woods VL
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1270-5. PubMed ID: 16514114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.